PCRX Pacira BioSciences Earnings and EPS analysis

EPS in 2026 (TTM): $0.35

Last Report Period Date: Jun 30, 2026

As of August 2026, according to Pacira BioSciences's latest financial report, the company's current EPS (TTM) is $0.35. In 2025, the company recorded an earnings per share (EPS) of $0.16, which represents an increase compared to its EPS of -$2.15 in 2024. Pacira BioSciences's earnings per share for the quarterly report ending on Jun 30, 2026 was $0.12.

The annual EPS in 2025 was $0.16, an increase of 107.4% from -$2.15 in 2024. For the quarter ending Jun 30, 2026, the EPS was $0.12, showing a 209.1% increase from the same quarter last year. The trailing twelve months (TTM) EPS as of June 2026 is $0.35. In 2024, the annual EPS was -$2.15, showing a decrease of 336.3% from 2023.

Pacira BioSciences has recorded an increase in EPS of 209.1% over the last 12 months (YoY, quarterly). For the last three years, PCRX recorded an average annual EPS growth rate of -23%. Pacira BioSciences had an average annual EPS growth rate of -45.8% over the last 5 years. Across the last decade, PCRX had an average annual EPS growth of 12.3%.